Telemedicine Startups funded by Y Combinator (YC) 2026

Clara is an AI primary care and longevity practice from the team that founded and grew Circle Medical to $100M in revenue. Our mission at Clara is to add one billion years of healthspan to humanity. We do this with an AI with deep clinical knowledge, coupled with the ability to sift through medical data to detect trends and patterns that could be missed. Unlike Claude or ChatGPT, Clara can see your medical data and then act. Chat with Clara as you would a doctor and Clara can help with you make sense of symptoms, get medication refills, order and understand labs, and achieve health goals. Medical recommendations are preliminary until one of our human medical providers in the loop reviews and approves them.

Scanbase makes it easy for medical companies to convert photos of rapid diagnostic tests into results. We do this by providing a simple API that any medical company can access.

Current Description: RTHM provides virtual-first care for complex illness including Long COVID, ME/CFS, POTS, and mast cell activation. Many clinics focus on teaching patients how to better cope with symptoms, which is helpful, but we don’t stop there. We develop collaborations & partnerships so our patients access to the most promising testing and root-cause directed early therapies for their illness(es) with the goal of simplifying and streamlining the most efficient and effective clinical pathways so they can be scaled in the form of low cost online modules overseen remotely by clinicians. In conjunction with clinical care, RTHM operates a clinical lab and collects deep molecular data with robust clinical context to develop AI-powered diagnostics and better ways of predicting which treatments may work best for whom.

Adoption of Telehealth 1.0 has dropped to <5% because it's inefficient and unintelligent. Ankr uses generative AI to recreate functions of clinic staff including front desk, medical assistants and scribe. This allows Doctors to "spin-up" virtual clinics on-demand, anytime, anywhere. An average clinic using Ankr generates $1M in new revenue/year. We integrate with all top EHRs and work with all types of clinics in mid- to large-sized healthcare organizations.

Instalab gives you direct access to all the preventative tests you need to do this year to stay on top of your health. Trusted by tens of thousands of top-performing founders, executives, and professional athletes.

Navigating chronic illness is an isolating and lonely process which ultimately reduces medical adherence and adversely impacts outcomes. There are over 100 deadly chronic conditions as 1 out of 2 Americans is currently living with at least 1 chronic condition. The US healthcare system has over $1 trillion dollars in direct costs. Medical adherence rates for therapeutic programs and medicine are only 50% because patients feel lonely, isolated, and unsupported in their chronic illness journey. Reviving Mind is an in-network telehealth provider that improves clinical outcomes and program adherence for the senior medicare and medicare-advantage population that is plagued with loneliness and chronic illness. This is done through a novel and proprietary clinical program and technology platform that integrates virtual, private, curated, and professionally led groups that scale up to 8-patients with individualized and goal oriented lifestyle medicine coaching that is automated but managed by a licensed provider. Scaling rapidly across the United States.

Equipt Health makes it easy for any healthcare company to offer prescription medical devices to patients. We handle the whole process: the packaging, the logistics, the clinical (via our provider network) and technical support, and the return of data from connected devices. We're starting with the diagnosis and treatment of sleep apnea at heliosleep.com.

Tuli health is turning all 11 000 independent pharmacies in the UK into diagnostic centers. Our software makes it easy for these pharmacies to sell and fulfill COVID-19 tests today and other diagnostic tests tomorrow. Instead of waiting for a long time or travelling a long distance to receive the tests, customers can now receive tests in their neighbourhood, with results guaranteed in 24 hours. Tuli Health was launched in June, had onboarded 147 pharmacies, performed over 7000 diagnostic tests, and helped pharmacies generate $1.3 million in incremental revenue per month. The vision is to make every local pharmacy into a diagnostic center powered by Tuli Health.

We make it easy for anyone in India to access healthcare over Zoom, Meet, or WhatsApp. We provide care in 11 local languages. For every appointment, we provide a concierge who manages all logistics for the patient & handles the back-office work for doctors. With this, we have cracked the code to make telehealth work in India.

Akute is an automation-first electronic medical health record system (EMR). It’s a co-pilot for digital health and direct primary care companies that are growing modern practices. Akute’s platform is fully programmable and customizable that enables clinical businesses to cut admin overhead and give time back to providers so they can spend more time with patients. In a space of legacy tech, our team and platform’s agility and exceptional customer support makes us stand out. Join a VC-backed company in its seed stage and help make real improvements to healthcare.

Rinse is building the One Medical for dental. Beautiful studios, easy to book same day appointments, and anxiety-free care focused on prevention, not the upsell.

Terapify offers high-quality on-demand mental healthcare for individuals and businesses. Currently, people in more than 45 countries take therapy with us on a recurring basis every month.

Every hospital hires clinical pharmacists to answer clinical questions from doctors. They outsource this to us because we’re more efficient.

PNOĒ enables health professionals to provide science-backed bio-optimization through breath analysis. For 100+ years, breath analysis (AKA metabolic testing, VO2max) has been the gold standard in anti-aging quantification, nutrition prescription, and evaluation of most critical systems, including the heart, lungs, cells, and nervous system. Until recently, it was only available in sophisticated clinics and regarded as the most valuable but underutilized assessment in medicine. PNOĒ changed that through the first easy-to-use clinical-grade breath analysis device, proprietary software package, and dedicated metabolic expert support. Through a non-invasive 10 min breath test, PNOĒ analyzes the human breath and prescribes a personalized nutrition, exercise, breathwork, and bio-optimization (i.e., red light therapy, hyperbaric chamber, IV therapy, etc.) program based on one’s biological limitations. 3,000+ health professionals trust PNOĒ because it personalizes the clients’ journey through their clinics, builds retention by quantifying progress, and enables the upsell of personalized nutrition and breathwork. All this without any effort, time commitment, or upfront cost. PNOĒ has been independently validated by Georgetown University, VA in Maryland, and Rutgers University and is trusted by leading institutions including Cenegenics, Dais Cove, MIT, UCLA, Pan Pacific, CLMBR, UCS, OURA, TONAL, Spartan Racing, and Paris Saint Germain.

We are making a new fertility treatment that infertile couples can order with a click of a button to help them conceive at home. Our technology increases the likelihood of pregnancy by guiding significantly higher number of sperms towards the ovum using a proprietary combination of surface features and microenvironment optimization. The fertility treatments available today, such as in-vitro fertilization (IVF) and intra-uterine insemination (IUI), are psychologically and financially draining and come with considerable treatment-associated risks. Furthermore, over 25 million women of reproductive age in the US have limited nearby access to fertility treatment.

Ophelia helps people quit opioids without going to rehab. We offer online doctor’s visits, withdrawal medication prescriptions, and support for long-term recovery, using a protocol 6x more effective than most rehabs (2/3rds of which don't have doctors). More than 3 million Americans are addicted to opioids, but 80% are not getting help, due to jobs, families, and privacy concerns. Meanwhile, there's a proven treatment that increases survival rates by 600%, and it's low cost, discreet, and convenient. It's called MAT, and it looks like treatment for anxiety or depression: medication plus therapy. However, doctors need a special waiver to prescribe the medication, which fewer than 5% of them have, so it's difficult to get, and most people are buying it on the street. Sadly, drug dealers aren't doctors: every 11 minutes another American dies of an opioid overdose, now the #1 cause of death for Americans under 50. Ophelia is replacing rehab with telemedicine, using proven science and a consumer-first approach. The opioid treatment market in the U.S. is $15B, and 85% of opioid addicts have insurance that pays for it. We're treating roughly 400 patients with thousands more waiting. Zack started Ophelia after losing his girlfriend to an opioid overdose, who found it easier to get medication from a drug dealer than a doctor. We are raising money to help patients in waiting, grow our footprint, save lives, and earn venture-level returns for investors.

Our overarching mission is to build the AI operating system for consumer healthcare - delivering end-to-end care with near-zero marginal human time. We believe the future of healthcare is automated, intelligent, radically lower cost, and built around the consumer. We believe biology is entering a golden age. We believe profitable, focused companies beat bloated ones. We're determined to get the humans out of healthcare - replacing slow, expensive, legacy workflows with software-driven care delivered at scale. We’ve started by building this infrastructure to power our own brands - including Bolt Pharmacy and Fella Health, among others. Today, that infrastructure is helping patients access life-changing treatment for excess bodyweight. Over time, we’ll extend it across many of the categories that will define the next era of healthcare. Our infrastructure will have served 100 million patients worldwide by 2035. We’ll then use that infrastructure to deliver next-generation healthcare products at massive scale. In doing so, we aim to build the world’s first trillion-dollar healthcare company.

MDalgorithms is revolutionizing dermatology by delivering convenient, effective AI-powered solutions for skin and hair care. Since pioneering machine-learning models for acne treatment in 2017, we’ve advanced to develop the world’s first AI-powered scalp analysis for hair regrowth. Our proprietary AI technology, built entirely in-house, analyzes blemishes, lesions, and hair conditions with unmatched precision, utilizing the largest global dataset of acne and scalp images. Clinically validated and tested by dermatologists, our personalized treatment kits—MDacne for acne and MDhair for hair regrowth—are customized to each individual’s unique needs, combining over 100 medical and botanical ingredients for optimal results. We empower users to track their progress, adjust treatments as needed, and access real-time support from our team of dermatologists and nurses. By doing so, we make personalized dermatological care accessible to all.

Qvin is the first and only healthcare service to scientifically prove menstrual blood can test for critical health information – just like a traditional laboratory blood test. Women's health has always been under-prioritized in science. We still operate in a world built by men, for men. It’s why in 2014, Dr. Sara Naseri and Søren Therkelsen started Qvin to research, develop, and patent a product that powers an underserved and understudied population—women. Over 70% of the decisions our doctors make are influenced by blood test results. Every month, 1.8 billion people across the world menstruate. However, the blood our bodies naturally deliver every month has never been explored as a testing source. And yet, menstrual blood has been left unexplored. Qvin is the first and only healthcare service to use period blood as a non-invasive blood test. We exist to give women an easy, insightful way to monitor existing health issues, proactively screen for others, and go into doctor visits more informed and confident of their own health. Our health technology platform helps women manage their health better through a non-invasive blood collection device named the Q-Pad™. All of us at Qvin want to move the study of women forward. We want to close the gender data gap. And we stand for every person who identifies with women, however they define it.

Bodyport’s cardiovascular sensing weight scale and predictive algorithms detect early changes in cardiac function to help prevent avoidable hospitalizations. Bodyport is initially targeting heart failure, a chronic condition affecting over 6M Americans and a leading cause of hospitalizations (1M/year) and healthcare spending ($35B/year). Bodyport’s novel scale measures cardiac output, congestion, heart rate, and other leading indicators of cardiovascular health — all in the same step patients already take to weigh themselves. Companion algorithms and software empower care teams to quickly identify at-risk patients and remotely optimize their therapy to prevent deterioration.

At Alfie, we've built a rigorous virtual medical program based on the top research from Cleveland Clinic and Harvard that allows us to precisely determine which weight loss regimen and (as needed) medications will be most effective for our members in a multimodal approach. We're optimizing exercise/nutrition/medications in complex care pathways like no one else has before. Our program has been shown to be 2x more effective than standard prescription medication and 5x more effective than habit change alone. We've raised capital from Goodwater Capital, Nina Capital, Air Force Ventures, and Phoenix Club, and various super angels including the founder of OpenTrons (medical labs automation; have raised $240 mill). Also, we're a Y Combinator graduate.

Dermatologist 👩🏻‍⚕️ virtual clinic in LATAM, with great dermatologists that consult, prescribe and send treatment to your doorstep In 🇲🇽 Mexico 8 out of 10 teenagers have acne, and there is only a ratio of 1 Dermatologist 👨🏽‍⚕️ per 50,000 🌎 population.

DrChrono develops the essential platform and services for modern medical practices to make care more informed, more interactive, and more personalized. The open platform powers telehealth, electronic health record (EHR), practice management, medical billing, and revenue cycle solutions for physicians and patients, and is fully extensible via a robust API and marketplace of applications and services. The platform is used by thousands of physicians and millions of patients, and is facilitating millions of patient appointments and is processing billions of dollars in medical billing. For more information about DrChrono, visit www.drchrono.com